VALERIE JUAREZ: Open Payments
NPI 1407967979 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,176 in 67 payments from 18 companies in 2025. Trend: 2023 $1,363 · 2024 $1,211 · 2025 $1,176
Food & beverage: $1,176
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $305 |
| Novo Nordisk Inc | 16 | $278 |
| GlaxoSmithKline, LLC. | 5 | $85 |
| Amgen Inc. | 5 | $74 |
| Phathom Pharmaceuticals, Inc. | 4 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49 |
| Abbott Laboratories | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| SANOFI PASTEUR INC. | 2 | $38 |
| Lilly USA, LLC | 2 | $30 |
Products named: Wegovy, VRAYLAR, SHINGRIX, JARDIANCE, VOQUEZNA, QULIPTA, UBRELVY, SYNTHROID.
Industry payments across UT — which companies pay providers there.
